2005, NucleaRDB.
This data was extracted from Medline abstracts and full texts (when available) in an automated manner.
The table below describes the selected point mutation and provides links to other documents. The sentence(s) where the point mutation C313S was found are listed after the table.
The mutated residues are also indicated in the family sequence alignments and hyperlinked to the corresponding mutation pages.
| Point mutation: | C313S | |
| Cited point mutation: | Cys313Ser,Cys313 | |
| Domain: | LBD HELIX 3 | |
| General numbering (NucleaRDB): | 335 | |
| Protein: | PPAT_HUMAN (PPARG,NR1C) | Swiss-Prot Cross-reference table Family page |
| Protein isoforms | 2 | |
| Other point mutations / same protein | List of mutations in PPAT_HUMAN | |
| Family alignments |
1C3 PPAR gamma 1C Peroxisome proliferator activated (PPAR) 1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR | |
| Other point mutations / same position |
Position 218 in 1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR family | |
| Reference: | T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, Amaral K, Nakamura M, Miao S, Cao P, Learned RM, Chen JL, Li Y J Biol Chem 2002 May 31;277(22):19649-57. | Medline |
| Other point mutations / same article | List | |
| Text source | HTML and PDF full texts | |
| Validation status | True positive |
Relevant sentences:
Cys313
C313S
cmbi.kun.nl), 21-Apr-2005